Using human data to protect the public's health

Regulatory Toxicology and Pharmacology

Volumn 33, Issue 2, 2001, Pages 234-256

  Dourson, Michael L ^a   Andersen, Melvin E ^b   Erdreich, Linda S ^c   MacGregor, Judith A ^d  

^a Toxicology Excellence for Risk Assessment   (United States)

^b Department of Ecosystem Science and Sustainability   (United States)

^c Exponent   (United States)

^d Toxicology Consulting Services   (United States)

Author keywords

Dose response; Human; Pharmacodynamics; Pharmacokinetics; Reference concentration; Reference dose; Risk; Uncertainty factor

Indexed keywords

1,1,2 TRICHLORO 1,2,2 TRIFLUOROETHANE; 2,4 DINITROPHENOL; ALDICARB; AMMONIA; ARSENIC; BARIUM; BENZOIC ACID; BERYLLIUM; CADMIUM; CARBON DISULFIDE; CHLORPYRIFOS; CHROMIUM; DICHLOROMETHANE; DRINKING WATER; ETHION; FLUORINE; HEAVY METAL; HEXANE; HYDROGEN CYANIDE; MALATHION; MANGANESE; METHYL BROMIDE; METHYLMERCURY; MOLYBDENUM; N,N DIMETHYLFORMAMIDE; NITRATE; NITRITE; PESTICIDE; PROPOXUR; SELENIUM; SILVER; STYRENE; TOLUENE; WARFARIN; ZINC;

ANIMAL MODEL; ARTICLE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; MOUSE; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SPECIES DIFFERENTIATION; TOXICITY TESTING; TOXICOKINETICS; WATER CONTAMINATION;

ANIMALIA; TRIXIS;

EID: 0035023846     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2001.1469     Document Type: Article

References (47)

1. Andersen, M. E., and Jarabek, A. M. (2000). Nasal tissue dosimetry -Issues and approaches for "Category I" gases: Areport on a meeting held in Research Triangle Park, NC, February 11-12, 1998. Inhal. Toxicol., in press.
2. Andersen, M. E., Sarangapani, R., Frederick, C. B., and Kimbell, J. S. (1999). Dosimetric adjustment factors for methylmethacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model. Inhal. Toxicol. 11, 899-926.
3. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., MacNaughton, M. G., Reitz, R. H., Nolan, R., and McKenna, M. (1991). Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharmacol. 108, 14-27.
4. Andersen, M. E., Clewell, H. J., III, Gargas, M. L., Smith, F. A., and Reitz, R. H. (1987). Physiologically-based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185-205.
5. Barnes, D. G., and Dourson, M. L. (1988). Reference dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8, 471-486.
6. Barton, H. A., Andersen, M. E., and Clewell, H. J., III (1998). Harmonization: Developing consistent guidelines for applying mode of action and dosimetry information to cancer and noncancer risk assessment. Hum. Ecol. Risk Assess. 4, 75-115.
7. Clewell, H. J. (1995). Incorporating biological information in quantitative risk assessment: An example with methylene chloride. Toxicology 102, 83-94.
8. Crump, K., Allen, B., and Shipp, A. (1989). Choice of dose measure for extrapolating carcinogenic risk from animals to humans: An empirical investigation of 23 chemicals. Health Phys. 57, 387-393.
9. DeGeorge, J. (1999). Transcript of the USEPA Joint Science Advisory Board/Science Advisory Panel, Data from Testing on Human Subjects Subcommittee, November 30, 1999.
10. Dourson, M. L. (1994). Methods for establishing oral reference doses (RfDs). In Risk Assessment of Essential Elements. (W. Mertz, C. O. Abernathy, and S. S. Olin, Eds.), pp. 51-61. ILSI Press, Washington, DC.
11. Dourson, M. L., Felter, S. P., and Robinson, D. (1996). Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24, 108-120.
12. Dourson, M. L., Meier, A., Meek, B., Renwick, A., Ohanian, E., and Poirier, K. (1998). Boron tolerable intake: Re-evaluation of toxicokinetics for data-derived uncertainty factors. Biol. Trace Elem. Res. 66(1-3), 453-463.
13. Elwood, J. M. (1998). Critical Appraisal of Epidemiological Studies and Clinical Trials, Oxford Univ. Press, Oxford.
14. EPA (Environmental Protection Agency) (1994). Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry, EPA/600/8-90-066F, October. Office of Health and Environmental Assessment, Washington, DC.
15. EPA (Environmental Protection Agency) (1999). The Office Of Pesticide Programs' Policy on Determination of the Appropriate FQPA Safety Factor(s) for Use in the Tolerance-Setting Process. May. Office of Pesticide Programs.
16. EPA (Environmental Protection Agency) (2000a). Science Advisory Board. Executive Committee Review Draft Report of the Joint SAB/SAP Subcommittee on Data from Testing of Human Subjects. Available at http://www.epa.gov/sab/Reports/2000report/2000drafts/Humandata. May 31, draft.
17. EPA (Environmental Protection Agency) (2000b). Integrated Risk Information System (IRIS). National Center for Environmental Assessment. See listing for individual chemicals and the glossary for risk assessment terms. Available online at http://wwrw.epa.gov/iris.
18. Felter, S. F., and Dourson, M. L. (1998). The inexact science of risk assessment (and implications for risk management). Human Ecol. Risk Assess 2, 245-251.
19. Frederick, C., Bush, M. L., Subramaniam, R. P., Black, K. A., Finch, L., Kimbell, J. S., Morgan, K. T., Morris, J. B., and Ultman, J. S. (1998). Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol. Appl. Pharmacol. 152, 211-231.
20. FDA (Food and Drug Administration) (1997). FDA Public Health Advisory, Reports of Valvular Heath Disease in Patients Receiving Concomitant Fenfluramine and Phentermine. July.
21. Gearhart, J. M., Jepson, G. W., Clewell, H. J., III, Andersen, M. E., and Conolly, R. B. (1990). A physiologically based model for in vivo inhibition of acetylcholinesterase by diisopropyl fluorophosphate. Toxicol. Appl. Pharmacol. 106, 295-310.
22. Gerlowski, L. E., and Jain, R. K. (1983). Physiologically based pharmacokinetic modeling: Principles and applications. J. Pharm. Sci. 72, 103-1127.
23. Hays, S., Aylward, L., Karch, N., and Paustenbach, D. (1997). The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-TCDD: An analysis using standard and internal measures of dose. Chemosphere 34(5-7), 1507-1522.
24. ILSI (International Life Sciences Institute) (1997). An evaluation of EPA's proposed guidelines for carcinogen risk assessment using chloroform and dichloroacetate as case studies: Report of an expert panel. November. Washington, D. C.
25. IPCS (International Programme on Chemical Safety) (1994). Derivation of guidance values for health-based exposure limits. Environmental Health Criteria No. 170: Assessing Human Health Risks of Chemicals. World Health Organization, Geneva.
26. Jarabek, A. M. (1994). Inhalation RfC methodology: Dosimetric adjustments and dose-response estimation of noncancer toxicity in the upper respiratory tract. Inhal. Toxicol. 6(Suppl.), 301-325.
27. Jarabek, A. M. (1995). The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches. Toxicol. Lett. 79, 171-184.
28. Lee, ET. (1980). Statistical Methods for Survival Data Analysis. Lifetime Learning Publications, CA.
29. MacGregor, J. T., Collins, J. M., Sugiyama, Y., Tyson, C. A., Dean, J., Smith, L., Andersen, M., Curren, R., Houston, J. B., Kadlubar, F. K., Kedderis, G. L., Krishnan, K., Li, A., Parchment, R. E., Thummel, K., Tomaszewski, J. E., Ulrich, R., Vickers, A. E. M., and Wrighton, S. A. (2000). In vitro Human tissue models in risk assessment: Report of a consensus-building workshop In vitro human tissue models in risk assessment. Toxicol. Sci., in press.
30. Meek, M. E., Newhook, R., Liteplo, R. G., and V. C. Armstrong. (1994). Approach to assessment of risk to human health for priority substances under the Canadian Environmental Protection Act. Environ. Carcinogen. Ecotoxicol. Rev. C12(2), 105-134.
31. Meek, B., Renwick, A., Ohanian, E., Dourson, M., Lake, B., Naumann, B., and Vu, V. (2001). Guidelines for application of compound specific adjustment factors (CSAF) in dose/concentration response assessment. In press.
32. Murray, F. J., and Andersen, M. E. (2000). Data-derived uncertainty factors: Boric acid (BA) as a case study. Hum. Ecol. Risk Assess., in press.
33. NAS (National Academy of Sciences) (1983). Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
34. NAS (National Academy of Sciences) (1994). Science and Judgment in Risk Assessment, National Academy Press, Washington, DC.
35. NCEA (National Center for Environmental Assessment) (2000). Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds. Online at http://www.epa.gov/ncea/pdfs/dioxin/dioxreass.htm.
36. NRC (National Research Council) (1986). Dose-Route Extrapolations: Using Inhalation Toxicity Data to Set Drinking Water Limits. Chapter 6, Drinking Water and Health, Volume 6: National Academy Press, Washington, DC.
37. Okoji, R., Leininger, J., and Froines, J. (1999). Subchronic toxicity study of sodium arsenite in methyl-deficient male C57BL/6 mice. In: Arsenic Exposure and Health Effects (W. Chappell, C. Abernathy, and R. Calderon, Eds.), pp. 225-232. Elsevier, Amsterdam, The Netherland.
38. Olson, H., Betton, G., Robinson, D., et al. (2000). Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32, 56-67.
39. Plowchalk, D. R., Andersen, M. E., and Bogdanffy, M. S. (1997). Physiologically-based modeling of vinyl acetate uptake, metabolism and intracellular pH changes in the rat nasal cavity. Toxicol. Appl. Pharmacol. 142, 386-400.
40. Reitz, R. H., Mendrela, A. L., and Guengerich, F. P. (1989). In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97, 230-246.
41. Renwick, A. G. (1993). Data derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit. Contam. 10(3), 275-305.
42. Renwick, A., and Lazarus, N. R. (1998). Human variability and noncancer risk assessment-An analysis of the default uncertainty factor. Regul. Toxicol. Pharmacol. 27, 3-20.
43. Russo, E. (2000). Monitoring human subjects and clinical trials. Scientist May 15, p. 6.
44. SOT (Society of Toxicology) (2000). The Value and Ethics of Using Human Data for the Registration of Pesticides. 39th Annual Meeting, March 23.
45. TERA (Toxicology Excellence for Risk Assessment) (2000). International Toxicity Estimates for Risk (ITER) Database. Online at www.tera.org.
46. Thomas, R. S., Bigelow, P. L., Keefe, T. J., and Yang, R. S. H. (1996). Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation. Amer. Ind. Hyg. Assoc. J. 57, 23-32.
47. Vaziri, N. D., and Oveisi, F. (2000). Evaluation of Renal Clearance of Boric Acid in Non-pregnant and Pregnant Sprague-Dawley Rats. Final Report. Univ. California, Irvine, April.